MATW vs. IOVA
MATW (Matthews International Corporation) and IOVA (Iovance Biotherapeutics, Inc.) are both stocks. MATW operates in Conglomerates (Industrials), while IOVA operates in Biotechnology (Healthcare). Over the past 10 years, MATW returned -4.38%/yr vs -6.39%/yr for IOVA. At a 0.17 correlation, their price movements are largely independent.
Performance
MATW vs. IOVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MATW achieves a 1.87% return, which is significantly lower than IOVA's 48.72% return. Over the past 10 years, MATW has outperformed IOVA with an annualized return of -4.38%, while IOVA has yielded a comparatively lower -6.39% annualized return.
MATW
- 1D
- -0.91%
- 1M
- -2.39%
- YTD
- 1.87%
- 6M
- 2.30%
- 1Y
- 29.23%
- 3Y*
- -9.69%
- 5Y*
- -2.96%
- 10Y*
- -4.38%
IOVA
- 1D
- 3.84%
- 1M
- -1.22%
- YTD
- 48.72%
- 6M
- 46.04%
- 1Y
- 105.05%
- 3Y*
- -20.47%
- 5Y*
- -30.33%
- 10Y*
- -6.39%
MATW vs. IOVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MATW Matthews International Corporation | 1.87% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
IOVA Iovance Biotherapeutics, Inc. | 48.72% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 212.77% | 10.62% | 15.11% |
Correlation
The correlation between MATW and IOVA is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Oct 15, 2010 | 0.17 |
Fundamentals
MATW:
$0.41
IOVA:
-$0.93
MATW:
0.51
IOVA:
5.42
MATW:
$1.21B
IOVA:
$285.61M
MATW:
$432.86M
IOVA:
$327.04M
MATW:
$201.65M
IOVA:
-$325.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MATW vs. IOVA — Risk / Return Rank
MATW
IOVA
MATW vs. IOVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Matthews International Corporation (MATW) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MATW | IOVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.24 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.85 | 1.94 | -0.09 |
| Martin ratioReturn relative to average drawdown | 4.26 | 3.05 | +1.21 |
Loading charts...
Drawdowns
MATW vs. IOVA - Drawdown Comparison
The maximum MATW drawdown since its inception was -75.27%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for MATW and IOVA.
Loading charts...
Drawdown Indicators
| MATW | IOVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.27% | -99.37% | +24.10% |
Max Drawdown (1Y)Largest decline over 1 year | -15.87% | -54.41% | +38.54% |
Max Drawdown (3Y)Largest decline over 3 years | -58.68% | -90.50% | +31.82% |
Max Drawdown (5Y)Largest decline over 5 years | -58.68% | -93.99% | +35.31% |
Max Drawdown (10Y)Largest decline over 10 years | -75.27% | -96.84% | +21.57% |
Current DrawdownCurrent decline from peak | -55.94% | -97.45% | +41.51% |
Average DrawdownAverage peak-to-trough decline | -24.75% | -84.18% | +59.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.88% | 34.61% | -27.73% |
Volatility
MATW vs. IOVA - Volatility Comparison
The current volatility for Matthews International Corporation (MATW) is 8.62%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 25.62%. This indicates that MATW experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MATW | IOVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.62% | 25.62% | -17.00% |
Volatility (6M)Calculated over the trailing 6-month period | 21.67% | 64.08% | -42.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.95% | 101.54% | -67.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.34% | 89.88% | -53.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.97% | 81.44% | -44.47% |
Dividends
MATW vs. IOVA - Dividend Comparison
MATW's dividend yield for the trailing twelve months is around 3.89%, while IOVA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MATW Matthews International Corporation | 3.89% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
Financials
MATW vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between Matthews International Corporation and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MATW and IOVA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (25.62%) compared to MATW (8.62%). In terms of maximum drawdown, MATW dropped -75.27% vs IOVA's -99.37%.
IOVA currently has the higher Sharpe Ratio (1.04 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MATW and IOVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer